Mechanistically, sotorasib treatment led to stabilization of BIM and co-treatment with DT2216 inhibited sotorasib-induced BCL-X<sub>L</sub>/BIM interaction leading to enhanced apoptosis in KRAS<sup>G12C</sup> tumor cell lines. Here, KRAS is linked to neoplasm.